Expiration date: 05/2026

Action:

antineoplastic

Composition:

temozolomide 20mg

auxiliary substances: lactose b/C

silica colloidal anhydrous, sodium carboximetilkrahmal, wine-TA, stearic-TA

Indications:

Malignant brain tumors (multiple glioblastoma, anaplastic astrocytoma) in the presence of relapse or progression of the disease after standard therapy. Common metastatic melanoma